GuptaSK, EustaceJA, WinstonJA, BoydstunII, AhujaTS, RodriguezRAet al.Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis, 2005; 40,11:1559–1585.
2.
ClumeckN, PozniakA, RaffiF. the EACS Executive Committee. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med, 2008; 9,2:65–71.
3.
CockcroftDW, GaultMH. Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 16,1:31–41.
4.
LeveyAS, BoschJP, LewisJB, GreeneT, RogersN, RothD. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999; 130,6:461–470.
5.
StevensLA, SchmidCH, GreeneT, ZhangYL, BeckGJ, FroissartMet al.Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis, 2010; 56,3:486–495.
6.
MatsushitaK, SelvinE, BashLD, AstorBC, CoreshJ. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis, 2010; 55,4:648–659.
7.
AntinoriA, MarcotullioS, AmmassariA, AndreoniM, AngaranoG, CarosiGet al.Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. New Microbiol, 2011; 34,2:109–146.
8.
OddenMC, ScherzerR, BacchettiP, SzczechLA, SidneyS, GrunfeldCet al.Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: The FRAM study. Arch Intern Med, 2007; 167,20:2213–2219.
9.
FillerG, BökenkampA, HofmannW, Le BriconT, Martínez-BrúC, GrubbA. Cystatin C as a marker of GFR––history, indications, and future research. Clin Biochem, 2005; 38,1:1–8.
10.
MasseyD. Commentary: Clinical diagnostic use of cystatin C. J Clin Lab Anal, 2004; 18,1:55–60.
11.
NeuhausJ, JacobsDRJr, BakerJVet al.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis, 2010; 201,12:1788–1795.
12.
BarracloughK, ErL, NgF, HarrisM, MontanerJ, LevinA. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract, 2009; 111,1:c39–48.
13.
OvertonET, PatelP, MondyK, BushT, ConleyL, RhameFet al.Cystatin C and baseline renal function among HIV-infected persons in the SUN Study. AIDS Res Hum Retroviruses, 2011; 27[Epub ahead of print]10.1089/aid.2011.0018.
14.
DabrowskaMM, MikulaT, StanczakW, MalyszkoJ, Wiercinska-DrapaloA. Comparative analysis of the new chronic kidney disease epidemiology collaboration and the modification of diet in renal disease equations for estimation of glomerular filtration rate in HIV type 1-infected subjects. AIDS Res Hum Retroviruses, 2011; 27,8:809–13.
15.
RavasiG, LauriolaM, TinelliC, BrandoliniM, UgliettiA, MaseratiR. Comparison of glomerular filtration rate estimates vs. 24-h creatinine clearance in HIV-positive patients. HIV Med, 2009; 10,4:219–228.
16.
BlandJM, AltmanDG. Comparing two methods of clinical measurements: A personal history. Int J Epidemiol, 1995; 24:S7–14.
17.
CesanaBM. Comparison of measurement methods requires appropriate statistical methodology. Am J Ophthalmol, 2004; 137:787–788.
18.
StevensLA, CoreshJ, SchmidCH, FeldmanHI, FroissartM, KusekJet al.Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis, 2008; 51,3:395–406.
19.
AlbiniL, CesanaBM, MottaD, FocàE, GottiD, CalabresiAet al.A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz. Acquir Immnue Defic Syndr., 2011Oct11[Epub ahead of print].
20.
DuboisD, DuboisEF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med, 1916; 17:863–871.
21.
LandisJR, KochGG. The measurement of observer agreement for categorical data. Biometrics, 1977; 33,1:159–174.
22.
BlandJM, AltmanDG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986; 1,8476:307–310.
23.
LinL I-K. A concordance correlation coefficient to evacuate reproducibility. Biometrics, 1989; 45:255–268.
24.
PassingH, Bablok. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem, 1983; 21,11:709–720.
25.
EstrellaMM, DerekM. Screening for chronic kidney disease in HIV-infected patients. Adv Chronic Kidney Dis, 2010; 17:26–35.
